Effect of Bacillus Coagulans and Galactomannans on Obese Patients Undergoing Sleeve Gastrectomy

Completed · Not applicable · Has a placebo group

Conditions studied: Obesity, Quality of Life

In brief

The purpose of the study is to determine the effect of bacillus coagulans and galactomannans (LactoWise®) administration on obese patients undergoing sleeve gastrectomy by observing standard protocol measurements in patients following sleeve gastrectomy: laboratory measurements, ideal body weight, and percent estimated weight loss, in addition incorporating the Gastrointestinal Quality of Life Index (GIQLI)

Key facts

Study ID

NCT02868489

Run by

Loma Linda University

People needed

60

Starts

2016-12-07

Expected to finish

2017-11-29

Last updated by the study team

2021-09-24

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient of bariatric sleeve surgery
• Ages 18-70
• Consent to complete GIQOL questionnaire
• Commit to consistent use of LactoWise® or placebo assigned for study period

You may not qualify if…

• None sleeve bariatric surgery patient
• Have compromised immunity or poorly controlled systems
• Presence of any concurrent active infection
• Physically disabled

Where it is running

• Faculty of Medical Offices - LLU — Loma Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.